Results 211 to 220 of about 48,956 (312)

Permanent visual impairment following a Behçet's disease flare while on calcitonin gene-related peptide receptor antagonist therapy: a case report. [PDF]

BMC Ophthalmol
Khan FA, Malik A, Nelson E, Fahimdanesh K, Kaur K, Elison J, Sayed M.   +6 more
europepmc   +1 more source

Adjuvant‐induced joint inflammation causes very rapid transcription of β‐preprotachykinin and α‐CGRP genes in innervating sensory ganglia [PDF]

, 2001
D. G. S. Bulling, David Kelly, Susan M. Bond, Daniel S. McQueen, Jonathan R. Seckl   +4 more
openalex   +1 more source

Exploring the epigenetic modifications of the RONS-TRPA1-CGRP axis in migraine pathophysiology. [PDF]

J Headache Pain
Fila M, Pawlowska E, Krekora J, Mitus-Kenig M, Blasiak J.   +4 more
europepmc   +1 more source

Distribution of calcitonine gene-related peptide Immuno-reactive (CGRP-IR) fibers in the rat stomach

, 1995
Terue Suzuki, Masatoyo Kagoshima, Niro Inaba, Sadayoshi Onodera, Hideyo Shimada   +4 more
openalex   +1 more source

Capsaicin‐evoked CGRP release from rat buccal mucosa: development of a model system for studying trigeminal mechanisms of neurogenic inflammation [PDF]

, 2001
Christopher M. Flores, Anthony S.‐Y. Leong, Gregory Dussor, Kenneth Hargreaves, Sonja Kilo   +4 more
openalex   +1 more source

Amylin/CGRP

, 2013
openaire   +3 more sources

Exposure Matching Using Population Pharmacokinetic Modeling and Simulation to Support Rimegepant Dose Selection for Pediatric Patients With Migraine

Clinical and Translational Science, Volume 18, Issue 10, October 2025.
ABSTRACT Rimegepant is a small molecule calcitonin gene‐related peptide receptor antagonist approved as a 75 mg orally disintegrating tablet for the acute treatment of migraine and the prevention of episodic migraine in adults. A population pharmacokinetic model for oral rimegepant was previously developed using data from 11 phase I studies in adults ...
Craig M. Comisar, Jim H. Hughes, Gary Mo, Rajinder Bhardwaj, Abhijeet Jakate, Chay Ngee Lim, Jing Liu   +6 more
wiley   +1 more source

Injection-Based Therapies for Migraine in Older Adults: A Narrative Review of OnabotulinumtoxinA, Greater Occipital Nerve Block, and Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies. [PDF]

J Korean Med Sci
Kang MK, Cho S, Kim BK, Moon HS, Lee MJ, Kim SK, Park HK, Chu MK, Ha WS, Kim BS, Cho SJ.   +10 more
europepmc   +1 more source

Effect of chronic administration of TCV-116, a novel nonpeptide angiotensin II receptor antagonist, on vasodilation mediated by calcitonin gene-related peptide (CGRP)-containing vasodilator nerves in spontaneously hypertensive rats (SHR).

, 1996
Masatoshi Okazaki, Yuichi Mimaki, Ritsuko Taniguchi, Hiromu Kawasaki, Yutaka Gomita   +4 more
openalex   +1 more source

Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals [PDF]

, 2001
Anette Sams‐Nielsen, Cathrine Ørskov, Inger Jansen‐Olesen   +2 more
openalex   +1 more source